查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1136991

细胞因子市场：按细胞因子类型、治疗用途、地区 - 规模、份额、前景、机会分析，2022-2028

Cytokine Market, By Cytokine Type, By Therapeutic Application, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细胞因子是一类在细胞信号传导中很重要的小蛋白。一种对调节其他免疫系统细胞和血细胞的生长和活性至关重要的小蛋白质。细胞因子影响所有血细胞和其他有助于身体免疫和炎症反应的细胞的生长。细胞因子是响应入侵病原体而产生的，以刺激、招募和增殖免疫细胞。细胞因子还通过发送信号杀死异常细胞并延长正常细胞的寿命来增强抗癌作用。此外，基于细胞因子的疗法可能为癌症、自身免疫性疾病和许多类型的传染病提供新的治疗方法。

市场动态

癌症治疗的广泛接受度、细胞因子作为新生儿败血症潜在生物标誌物的使用增加、干细胞治疗的潜在贡献以及 COVID-19 的爆发预计将有助于增长全球细胞因子市场。是一些关键因素那

细胞因子是分子信使，使免疫系统的细胞能够相互交流，并引发对目标抗原的协调、强大但自限性的反应。有两种类型的细胞因子用于治疗癌症患者：干扰素 (INF) 和白细胞介素 (IL)。因此，随着癌症患病率的增加，细胞因子在癌症治疗中的应用也在增加。

例如，根据 GLOBOCAN 2020 报告，美国约有 2,556,022 人患有癌症，预计到 2035 年这一数字将达到 3,316,283 人。预计越来越多的癌症患者将推动市场的增长。

本研究的主要特点

  • 本报告对全球细胞因子市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR %)。
  • 它还阐明了各个细分市场的潜在收入机会，并描述了对该市场有吸引力的投资主张矩阵。
  • 它还提供有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争策略等方面的重要见解。
  • 基于公司亮点、产品组合、关键亮点、经营成果和战略等参数的全球细胞因子市场主要参与者的概况。
  • 本研究涵盖的主要公司包括 Biocon Limited、Johnson & Johnson、Abbvie Inc.、UCB S.A.、Astra Zeneca PLC、Sanofi SA、Pfizer Inc.、Novartis International AG、Amgen Inc. 和 GlaxoSmithKline PLC，其中其他。
  • 本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。.
  • 全球细胞因子市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者通过用于分析全球细胞因子市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 举报内容
    • 市场定义和范围
  • 执行摘要
    • 市场快照：按细胞因子类型
    • 市场快照：按治疗应用
    • 市场概况：按地区划分
  • 连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

  • 市场动态
    • 全球癌症发病率上升
    • 细胞因子治疗费用高
    • 增加细胞因子的诊断和治疗应用
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/批准
  • PEST 分析
  • PORTER 分析
  • 併购方案

第 4 章全球细胞因子市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学特征
  • 供应方和需求方分析
  • 经济影响

第 5 章全球细胞因子市场，按细胞因子类型，2017-2028 年

  • 肿瘤坏死因子-TNF
  • 白介素-IL
  • 干扰素-IFN
  • 表皮生长因子-EGF
  • 其他细胞因子类型

第 6 章全球细胞因子市场，按治疗用途，2017-2028 年

  • 癌症
  • 支气管哮喘和气道炎症
  • 关节炎
  • 其他治疗用途

第 7 章全球细胞因子市场，按地区分列，2017-2028 年

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地区

第 8 章竞争格局

  • Biocon Limited
  • Johnson & Johnson
  • Abbvie Inc.
  • UCB S.A.
  • Astra Zeneca PLC
  • Sanofi SA
  • Pfizer Inc.
  • Novartis International AG
  • Amgen Inc.
  • GlaxoSmithKline PLC

第九章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5238

Cytokines are a category of small proteins important in cell signaling. They are small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells. Cytokines affect the growth of all blood cells and other cells that help the body's immune and inflammation responses. They are produced in response to invading pathogens to stimulate, recruit, and proliferate immune cells. Cytokines also help boost anti-cancer activity by sending signals that can help make abnormal cells die and normal cells live longer. Moreover, cytokine-based therapies have the potential to provide novel treatments for cancer, autoimmune diseases, and many types of infectious disease.

Market Dynamics:

Increased acceptance in cancer therapy, increase in use of cytokine as a potential biomarker for neonatal sepsis, potential contribution in stem cell therapy, and the outbreak of COVID-19 are some major factors expected to aid in the growth of the global cytokine market.

Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen. There are two types of cytokines used to treat patients with cancer, such as interferons (INFs) and interleukins (ILs). Thus, with the increase in prevalence of cancer, the adoption of cytokine in cancer therapy is also increasing.

For instance, as per the report from GLOBOCAN 2020, around 2,556,022 people in the United States were affected with cancer and this number is expected to reach 3,316,283 by 2035. The rise in cancer cases is expected to boost the growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global cytokine market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cytokine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Biocon Limited, Johnson & Johnson, Abbvie Inc., UCB S.A., Astra Zeneca PLC, Sanofi SA, Pfizer Inc., Novartis International AG, Amgen Inc., and GlaxoSmithKline PLC, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market.

Detailed Segmentation:

  • Global Cytokine Market, By Cytokine Type:
    • Tumor Necrosis Factor-TN
    • Interleukins-IL
    • Interferons-IFN
    • Epidermal Growth Factor-EGF
    • Other Cytokine Types
  • Global Cytokine Market, By Therapeutic Application:
    • Cancer
    • Asthma and Airway Inflammation
    • Arthritis
    • Other Therapeutic Applications
  • Global Cytokine Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Biocon Limited
    • Johnson & Johnson,
    • Abbvie Inc.
    • UCB S.A.
    • Astra Zeneca PLC
    • Sanofi SA
    • Pfizer Inc.
    • Novartis International AG
    • Amgen Inc.
    • GlaxoSmithKline PLC

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Cytokine Type
    • Market Snapshot, By Therapeutic Application
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in burden of cancer around the world
    • High cost of cytokines-based therapies
    • Rising number of diagnostic and therapeutic applications of cytokines
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Cytokine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cytokine Market, By Cytokine Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Tumor Necrosis Factor-TNF
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Interleukins-IL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Interferons-IFN
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Epidermal Growth Factor-EGF
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Cytokine Types
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Cytokine Market, By Therapeutic Application, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Asthma and Airway Inflammation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Therapeutic Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Cytokine Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Biocon Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbvie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • UCB S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astra Zeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us